13th Nov 2007 07:01
Advanced Medical Solutions Grp PLC13 November 2007 For Immediate Release 13 November 2007 Advanced Medical Solutions Group plc ("AMS" or "the Group") UK launch of ActivHeal(R) AquaFiber(R) wound dressing offers further savings for the NHS Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces the UK launch of ActivHeal(R)AquaFiber(R), a new advanced woundcare dressing that can deliver significantcost and care benefits to the NHS. The product will be unveiled today at theWounds UK 2007 Woundcare Conference in Harrogate, North Yorkshire. ActivHeal(R) AquaFiber(R) is a soft, conformable and highly absorbent dressing.In contact with wound exudate, the product forms a soft, clear gel providing anideal moist wound environment that supports the wound healing process. Indicatedfor moderate to heavily exuding chronic and acute wounds, ActivHeal(R) AquaFiber(R) also controls minor bleeding in superficial wounds. The ActivHeal(R) range of products is designed and manufactured by AMS tocombine cost savings with technological innovation with the objective ofoffering the NHS a cost-effective alternative to branded woundcare products. ActivHeal(R) AquaFiber(R) competes in a segment of the advanced woundcare marketon which it is estimated that the NHS currently spends £15 million each year.The ActivHeal(R) AquaFiber(R) dressing has been listed in the Drug Tariff and isavailable for prescribing by NHS Trusts at an average price 30% lower than theequivalent branded dressing, thus offering a significant immediate saving on NHSwoundcare budgets. In a poster presented at the Harrogate conference, ActivHeal(R) AquaFibre(R) wasshown to be equivalent or better to a significantly more expensive leading brandon all five performance characteristics tested including absorbency, speed ofabsorbency, dry strength, wet strength and lateral wicking - all key attributesof a moist wound healing dressing. Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS,stated: "The addition of the new ActivHeal(R) AquaFiber(R) product to our ActivHeal(R)range is another major step in providing advanced woundcare products to the NHSthat allow hospital and Primary Care Trusts to achieve substantial savingswithout compromising patient care." For further information, please contact: Advanced Medical Solutions Group plc Don Evans, Chief Executive Officer Tel: +44 (0) 1606 545508 Mary Tavener, Finance Director www.admedsol.com Buchanan Communications Mark Court, Mary-Jane Johnson Tel: +44 (0) 20 7466 5000 Landsbanki Securities (UK) Ltd Tel: +44 (0) 20 7426 9000 Shaun Dobson / Xavier de Mol Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on thedesign, development and manufacture of innovative and technologically advancedproducts for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove a product from design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing topical wounds sold direct to hospitals or throughdistributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group